Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetes
(Q33670828)
scientific article
scientific article
Language:
Current Data About
Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetes
other details
description | scientific article |
External Links
(P356) |
10.1046/J.1365-2362.1999.00005.X
|
(P698) |
10383608
|